Check-Cap (CHECK): What the Hell Has Happened
Medical diagnostics company Check Cap (NASDAQ:CHEK) is a puzzle. In the last two trading days, …
vTv Therapeutics (VTVT) Stock: Healthcare Analysts Move to the Sidelines
Last week, vTv Therapeutics Inc (NASDAQ:VTVT) announced that azeliragon, the company’s RAGE inhibitor in development …
Bristol Myers Squibb (BMY) Will Face Significant Headwinds in 2019; Here’s Why
Yesterday, Merck (NYSE:MRK) reported data from Keytruda in combo with chemotherapy for patients with non-small …
Why GW Pharmaceuticals (GWPH) Stock Is Posting Strong Gains Today
GW Pharmaceuticals (NASDAQ:GWPH) is a mover and shaker out on the Street today, with investors …
J.P. Morgan Shares Two Cents on Dynavax Technologies’ (DVAX) AACR Update
J.P. Morgan analyst Anupam Rama is out today with a brief research note on shares of Dynavax …
TherapeuticsMD’s (TXMD) TX-004 Takes a Step Forward to FDA Approval, Says Cantor
TherapeuticsMD (NASDAQ:TXMD) investors have a smile on their faces Wednesday, after the drug maker disclosed that …
Acadia Pharmaceuticals (ACAD): Another Glimpse Into Nuplazid Safety Profile
Acadia Pharmaceuticals (NASDAQ:ACAD) is a biopharmaceutical company based in San Diego and focused on the …
AveXis (AVXS) Takeover Validates the Paradigm-Shifting Nature of AVXS-101, Says William Blair
It’s a big day for AveXis (NASDAQ:AVXS). The drug maker has reached an agreement to be acquired …
Guggenheim Bullish on Menlo Therapeutics (MNLO) Despite Clinical Trial Setback
Small-cap biotech stocks are often considered “binary” lottery-ticket type events, with either a small chance …
Incyte (INCY) Shares Remain Attractive, Says Top Analyst
This morning, Incyte (NASDAQ:INCY) announced that the company’s ECHO-301 study comparing epacadostat in combination with …